Literature DB >> 9267664

Fear-potentiated startle in two strains of inbred mice.

W A Falls1, S Carlson, J G Turner, J F Willott.   

Abstract

The fear-potentiated startle paradigm has been used with great success to examine conditioned fear in both rats and humans. The purpose of this study was to examine fear-potentiated startle in inbred mice. One-month-old C57BL/6J (C57) and DBA/2J (DBA) mice were given tone + foot shock training trials. The amplitude of the acoustic startle reflex was measured in the presence and absence of the tone both before and after training. Both strains showed fear-potentiated startle after training as evidenced by larger startle amplitudes in the presence of the tone than in its absence. However, the magnitude of fear-potentiated startle was greater in DBA mice than in C57 mice. These results not only demonstrate fear-potentiated startle in mice for the first time but also suggest that fear-potentiated startle can be influenced by characteristics of the mouse strain.

Entities:  

Mesh:

Year:  1997        PMID: 9267664

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  26 in total

1.  Reduction of fear-potentiated startle by benzodiazepines in C57BL/6J mice.

Authors:  Kiersten S Smith; Edward G Meloni; Karyn M Myers; Ashlee Van't Veer; William A Carlezon; Uwe Rudolph
Journal:  Psychopharmacology (Berl)       Date:  2010-10-05       Impact factor: 4.530

2.  Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse.

Authors:  Beth A Costine; Joseph G Oberlander; Matthew C Davis; Carlos A A Penatti; Donna M Porter; Robert N Leaton; Leslie P Henderson
Journal:  Psychoneuroendocrinology       Date:  2010-05-26       Impact factor: 4.905

3.  Olfactory-mediated fear conditioning in mice: simultaneous measurements of fear-potentiated startle and freezing.

Authors:  Seth V Jones; Scott A Heldt; Michael Davis; Kerry J Ressler
Journal:  Behav Neurosci       Date:  2005-02       Impact factor: 1.912

4.  Behavioral characterization of P311 knockout mice.

Authors:  Gregory A Taylor; Ramona M Rodriguiz; Robert I Greene; Xiaoju Daniell; Stanley C Henry; Kristy R Crooks; Robert Kotloski; Lino Tessarollo; Lindsey E Phillips; William C Wetsel
Journal:  Genes Brain Behav       Date:  2008-06-30       Impact factor: 3.449

Review 5.  The autism diagnosis in translation: shared affect in children and mouse models of ASD.

Authors:  Somer L Bishop; Garet P Lahvis
Journal:  Autism Res       Date:  2011-08-31       Impact factor: 5.216

6.  The effect of transient increases in kynurenic acid and quinolinic acid levels early in life on behavior in adulthood: Implications for schizophrenia.

Authors:  Hannah F Iaccarino; Raymond F Suckow; Shan Xie; David J Bucci
Journal:  Schizophr Res       Date:  2013-09-30       Impact factor: 4.939

7.  Mice lacking synapsin III show abnormalities in explicit memory and conditioned fear.

Authors:  B Porton; R M Rodriguiz; L E Phillips; J W Gilbert; J Feng; P Greengard; H-T Kao; W C Wetsel
Journal:  Genes Brain Behav       Date:  2009-11-24       Impact factor: 3.449

8.  Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse.

Authors:  Qian Chen; Akira Nakajima; Corbin Meacham; Ya-Ping Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-28       Impact factor: 11.205

Review 9.  Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety.

Authors:  Michael Davis; David L Walker; Leigh Miles; Christian Grillon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

10.  Individual Differences in Animal Stress Models: Considering Resilience, Vulnerability, and the Amygdala in Mediating the Effects of Stress and Conditioned Fear on Sleep.

Authors:  Laurie L Wellman; Mairen E Fitzpatrick; Olga Y Hallum; Amy M Sutton; Brook L Williams; Larry D Sanford
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.